Korro Bio, Inc. (KRRO) › Shareholders' EquityKorro Bio, Inc. (KRRO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$9.66M2017: -$29.64M2018: -$48.28M2019: $167.36M2020: $192.49M2021: -$42.21M2022: -$99.03M2023: $169.91M2024: $160.41M2025: $51.44M$51.44M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$51.44M-67.9%2024$160.41M-5.6%2023$169.91M+271.6%2022-$99.03M-134.6%2021-$42.21M-121.9%2020$192.49M+15.0%2019$167.36M+446.6%2018-$48.28M-62.9%2017-$29.64M-206.8%2016-$9.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share